Filing Details

Accession Number:
0001246360-17-002232
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-21 18:49:11
Reporting Period:
2017-06-20
Filing Date:
2017-06-21
Accepted Time:
2017-06-21 18:49:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1195852 W Matthew Towse 350 Merrimack Street
Lawrence MA 01843
Svp And Chief Financial Office No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-20 4,300 $14.05 29,637 No 4 M Direct
Common Stock Disposition 2017-06-20 4,300 $23.29 25,337 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-06-20 4,300 $0.00 4,300 $14.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,930 2014-07-15 2023-07-14 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016.